eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention.
.
.
.
.
.
share on facebook facebook
.
robert, from los angeles, had four children from a previous marriage when he met helen through friends in the early 1960s.
.
.
.
.